WNK2 and rheumatoid arthritis: Astragalin could attenuate synovial inflammation and joint destruction in RA at least partially by restraining the phosphorylation of mitogen-activated protein kinases and the activating of N-terminal kinase/activated protein 1 (Zhang and Wei, 2020).